Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2021

View Archived Issues

Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer

Camino studies SBP-9330 in first-in-human trial for smoking cessation

New Toll-like receptor 7 agonists identified at Bristol Myers Squibb

Vertex Pharmaceuticals presents new apolipoprotein L1 inhibitors

New CREB-2 inhibitors discovered at Evotec International

Memorial Sloan-Kettering Cancer Center describes prodrugs useful in adoptive cell therapy

Mutational profiling gives clues to development, new puzzles about disease

Blade receives IND clearance for phase I study of cudetaxestat for IPF

Data presented for Almirall's JAK inhibitor LAS-200019

Janssen targets DHODH with new compounds for acute myelogenous leukemia

HUTCHMED begins phase Ib/II study of fruquintinib with tislelizumab in TNBC and endometrial cancer

New phase I/II trial investigates RVU-120 in relapsed/refractory metastatic or advanced solid tumors

CPI-613 advances into phase II evaluation in biliary tract cancer

Phase II trial of izokibep in ankylosing spondylitis commences dosing

Epeleuton shows promise in hamster model for SARS-CoV-2 infection

Mutation in RAPGEF1 gene tied to global developmental delay syndrome

Phase II study of SHR-0302 in alopecia areata meets primary efficacy endpoint

Studies reveal efficacy and mechanism of SARS-CoV-2-neutralizing antibody SC-31

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...